Image

A Study of Toripalimab in Combination With Cisplatin and Gemcitabine in Participants With Recurrent Metastatic Nasopharyngeal Cancer

Exploring new treatment options for recurring nasopharyngeal cancer.

Recruiting
12 years and older
All
Phase 4
  • Simplified description (AI rewritten)
  • Technical description (Original)

This study looks at how well a new medicine called toripalimab works with chemotherapy for people with nasopharyngeal cancer that has come back or spread. Nasopharyngeal cancer affects the area behind the nose and throat. The study uses two chemotherapy drugs: cisplatin and gemcitabine. The main goal is to see how many people respond to this treatment by measuring the size of their tumors with special guidelines (RECIST v1.1). To join, participants need to have a specific type of cancer confirmed by tests and have already tried other treatments without success. They should not have cancer that could be treated with local therapy aimed to cure it, or have had other treatments for their spreading cancer recently. Also, they should not have severe symptoms like uncontrolled pain or untreated cancer in the brain.

  • Participants need to visit the study center for check-ups and treatment.
  • There might be risks and side effects from the treatment.
  • Participants may receive compensation for their time and travel.
Print
Study details
    Nasopharyngeal Cancer Recurrent

NCT06457503

Coherus Biosciences, Inc.

21 June 2025

Contact a study center
Step 1 Get in touch with the nearest study center
We have submitted the contact information you provided to the research team at {{SITE_NAME}}. A copy of the message has been sent to your email for your records.
Would you like to be notified about other trials? Sign up for Patient Notification Services.
Sign up

Send a message

Enter your contact details to connect with study team

Investigator Avatar

Primary Contact

  Other languages supported:

First name*
Last name*
Email*
Phone number*
Race
Ethnicity
Other language

FAQs

Learn more about clinical trials

What is a clinical trial?

A clinical trial is a study designed to test specific interventions or treatments' effectiveness and safety, paving the way for new, innovative healthcare solutions.

Why should I take part in a clinical trial?

Participating in a clinical trial provides early access to potentially effective treatments and directly contributes to the healthcare advancements that benefit us all.

How long does a clinical trial take place?

The duration of clinical trials varies. Some trials last weeks, some years, depending on the phase and intention of the trial.

Do I get compensated for taking part in clinical trials?

Compensation varies per trial. Some offer payment or reimbursement for time and travel, while others may not.

How safe are clinical trials?

Clinical trials follow strict ethical guidelines and protocols to safeguard participants' health. They are closely monitored and safety reviewed regularly.
Add a private note
  • abc Select a piece of text.
  • Add notes visible only to you.
  • Send it to people through a passcode protected link.